Letter: Are Sorafenib-Related Adverse Events Associated With Prolonged Survival? Authors' Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15572
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

mRECIST Response Combined With Sorafenib-Related Adverse Events Is Superior to Either Criterion Alone in Predicting Survival in HCC Patients Treated With TACE Plus Sorafenib

International Journal of Cancer
Cancer ResearchOncology
2016English

Are Residents' Extended Shifts Associated With Adverse Events?

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2006English

Inflammatory Adverse Events Are Associated With Disease-Free Survival After Vaccine Therapy Among Patients With Melanoma

Annals of Surgical Oncology
OncologySurgery
2014English

Letter: Eluxadoline-Associated Acute Pancreatitis-Myth or Reality? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Sorafenib-Related Adverse Events in Predicting the Early Radiologic Responses of Hepatocellular Carcinoma

Gastroenterology Research
2019English

Authors Reply Letter to the Reviewers

2020English

Editorial: Sorafenib Toxicity, a Biomarker of Effect? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Predicting Azathioprine-Associated Pancreatitis in IBD-phenotype or Genotype? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy